BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35621687)

  • 21. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
    Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
    BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
    Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
    Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer.
    Nov P; Du K; Huang Z; Li Y; Gong M; Liu X; Li C; Li L; Wang D; Zhang Y; Wang C; Li J
    J Gastrointest Cancer; 2023 Sep; 54(3):693-702. PubMed ID: 36243897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
    Xu T; Feng L; Zhang W; Li H; Ma H; Abulimiti M; Tan Y; Deng F; Huang W; Zou S; Kang W; Jiang L; Wang Y; Hu C; Chen Y; Zhou H; Tang Y; Jin J
    BMC Cancer; 2024 Apr; 24(1):501. PubMed ID: 38641773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
    Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Borelli B; Conca V; Carullo M; Sainato A; Mattioni R; Manfredi B; Balestri R; Buccianti P; Morelli L; Rossi P; Vagli P; Prete AA; Luca F; Morano F; Donato SD; Salvatore L; Bengala C; Rossini D; Boni L; Antoniotti C; Cremolini C; Masi G; Moretto R
    Clin Colorectal Cancer; 2023 Sep; 22(3):339-343.e3. PubMed ID: 37429749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Findings in magnetic resonance imaging for restaging locally advanced rectal cancer.
    Marjasuo S; Koskenvuo L; Lepistö A
    Int J Colorectal Dis; 2024 Jan; 39(1):23. PubMed ID: 38289485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
    Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
    Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial.
    Golo D; But-Hadzic J; Anderluh F; Brecelj E; Edhemovic I; Jeromen A; Omejc M; Oblak I; Secerov-Ermenc A; Velenik V
    Radiol Oncol; 2018 Sep; 52(3):267-274. PubMed ID: 30210040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.
    Jalil O; Claydon L; Arulampalam T
    J Gastrointest Cancer; 2015 Sep; 46(3):219-36. PubMed ID: 26133151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.
    Petrelli F; Sgroi G; Sarti E; Barni S
    Ann Surg; 2016 Mar; 263(3):458-64. PubMed ID: 24263329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
    Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
    [No Abstract]   [Full Text] [Related]  

  • 33. Organ preservation following short-course radiotherapy for rectal cancer.
    Nilsson PJ; Ahlberg M; Kordnejad S; Holm T; Martling A
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34686879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 36. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Donnelly M; Ryan OK; Ryan ÉJ; Creavin B; O'Reilly M; McDermott R; Kennelly R; Hanly A; Martin ST; Winter DC
    Br J Surg; 2023 Sep; 110(10):1316-1330. PubMed ID: 37330950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
    Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M
    Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial).
    Akiyoshi T; Shinozaki E; Taguchi S; Chino A; Hiratsuka M; Tominaga T; Nonaka T; Toda S; Matoba S; Matsui S; Okabayashi K; Mukai T; Hiyoshi Y; Yamaguchi T; Nagasaki T; Yamaguchi K; Ueno M; Kuroyanagi H; Fukunaga Y; Ishizuka N; Konishi T;
    BMJ Open; 2022 Mar; 12(3):e055140. PubMed ID: 35304396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Wu Q; Zhou J; Huang J; Deng X; Li C; Meng W; He Y; Wang Z
    Br J Surg; 2023 Jun; 110(7):784-796. PubMed ID: 37191308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tegafur-Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer.
    Liao CK; Kuo YT; Chern YJ; Hsu YJ; Lin YC; Yu YL; Hsieh PS; Chiang JM; Yeh CY; You JF
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35629045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.